These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Medication management after intramedullary nailing of atypical fractures. Feron JM; Cambon-Binder A Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365 [TBL] [Abstract][Full Text] [Related]
7. Use of teriparatide in osteoporotic fracture patients. Collinge C; Favela J Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289 [TBL] [Abstract][Full Text] [Related]
8. New approaches to the treatment of osteoporosis. Silva BC; Bilezikian JP Annu Rev Med; 2011; 62():307-22. PubMed ID: 21054170 [TBL] [Abstract][Full Text] [Related]
9. Clinical Management of Osteoporotic Fractures. Khan AZ; Rames RD; Miller AN Curr Osteoporos Rep; 2018 Jun; 16(3):299-311. PubMed ID: 29637519 [TBL] [Abstract][Full Text] [Related]
10. Effect of osteoporosis medications on fracture healing. Hegde V; Jo JE; Andreopoulou P; Lane JM Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471 [TBL] [Abstract][Full Text] [Related]
12. [Morphological analysis of bone dynamics and metabolic bone disease. Histological findings in animal fracture model--effects of osteoporosis treatment drugs on fracture healing process]. Mashiba T Clin Calcium; 2011 Apr; 21(4):551-8. PubMed ID: 21447922 [TBL] [Abstract][Full Text] [Related]
13. Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment. Grover M; Bachrach LK Curr Osteoporos Rep; 2017 Aug; 15(4):271-282. PubMed ID: 28620868 [TBL] [Abstract][Full Text] [Related]
14. Short-term and long-term effects of osteoporosis therapies. Reid IR Nat Rev Endocrinol; 2015 Jul; 11(7):418-28. PubMed ID: 25963272 [TBL] [Abstract][Full Text] [Related]
15. Bone forming agents for the management of osteoporosis. Reginster JY; Neuprez A; Beaudart Ch; Buckinx F; Slomian J; Disteche S; Bruyere O Panminerva Med; 2014 Jun; 56(2):97-114. PubMed ID: 24642527 [TBL] [Abstract][Full Text] [Related]
16. Update on the Comprehensive Approach to Fragility Fractures. Cohn MR; Gianakos AL; Grueter K; Rosen N; Cong GT; Lane JM J Orthop Trauma; 2018 Sep; 32(9):480-490. PubMed ID: 30036208 [TBL] [Abstract][Full Text] [Related]
17. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Bilezikian JP Curr Osteoporos Rep; 2008 Mar; 6(1):24-30. PubMed ID: 18430397 [TBL] [Abstract][Full Text] [Related]
18. Osteoporosis in 2011: Osteoporosis therapy--dawn of the post-bisphosphonate era. Baron R Nat Rev Endocrinol; 2011 Dec; 8(2):76-8. PubMed ID: 22143180 [TBL] [Abstract][Full Text] [Related]
19. Real-world challenges of treating osteoporosis. Owens G Am J Manag Care; 2011 May; 17 Suppl 6():S177-84. PubMed ID: 21882487 [TBL] [Abstract][Full Text] [Related]
20. [Management of osteoporosis after fragility fractures]. Gosch M; Stumpf U; Kammerlander C; Böcker W; Heppner HJ; Wicklein S Z Gerontol Geriatr; 2018 Jan; 51(1):113-125. PubMed ID: 29305651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]